Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.084 AUD 2.44% Market Closed
Market Cap: 88.3m AUD

Wall Street
Price Targets

PTX Price Targets Summary
Prescient Therapeutics Ltd

There are no price targets for PTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Prescient Therapeutics Ltd Competitors:
Price Targets
FYB
Formycon AG
96% Upside
RYTM
Rhythm Pharmaceuticals Inc
29% Upside
LTRN
Lantern Pharma Inc.
571% Upside
688105
Nanjing Vazyme Biotech Co Ltd
44% Upside
ATRA
Atara Biotherapeutics Inc
12% Upside
IMMU
Mendus AB (publ)
210% Upside
688382
InventisBio Co Ltd
84% Upside
IMNM
Immunome Inc
62% Upside

Revenue
Forecast

Revenue Estimate
Prescient Therapeutics Ltd

For the last 13 years the compound annual growth rate for Prescient Therapeutics Ltd's revenue is 3%.

3%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PTX's stock price target?
Not Available

PTX doesn't have any price targets made by Wall Street professionals.

Back to Top